Entering text into the input field will update the search result below

Pfizer, Moderna win FDA backing for COVID shots in kids ahead of AdCom review

Jun. 13, 2022 6:53 AM ETPfizer Inc. (PFE) StockMRNA, BNTXBy: Dulan Lokuwithana, SA News Editor4 Comments

Headquarters of US Food and Drug Administration (FDA)

Grandbrothers/iStock Editorial via Getty Images

The U.S. Food and Drug Administration (FDA) has issued favorable remarks on the COVID-19 vaccines developed by Pfizer (NYSE:PFE)/BioNTech (BNTX) and Moderna (MRNA) for younger children as a group

Recommended For You

About PFE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PFE--
Pfizer Inc.